TargeGen, Incorporated.

Contact Details: 9393 Towne Centre Dr. Ste. 120 San Diego CA 92121 United States of America Tel: 858-678-0760 Fax: 858-678-0762 Email: WWW: www.targegen.com

Loading...

BioNews Results for TargeGen, Incorporated.:
TargeGen Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patient	PR Newswire:  Oct 28 2009 12:23PM Matching: targegen
TargeGen Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patient	Pharma Live:  Oct 25 2009 1:47AM Matching: targegen
TargeGen Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients	SmartBrief:  Oct 22 2009 11:50PM Matching: targegen
TargeGen, Inc. Announces Successful Completion of Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis P	BioSpace:  Oct 23 2009 5:52PM Matching: targegen
TargeGen completes JAK2 inhibitor TG101348 clinical trial in myelofibrosis patients	News-Medical.Net:  Oct 23 2009 4:51AM Matching: targegen
Promote your company here: BioNewsCast - Press Release Distribution	→View more TargeGen, Incorporated. news.

TargeGen, Incorporated. Patents:
US Patent No.	Title
7528143	Bi-aryl meta-pyrimidine inhibitors of kinases
7456176	Benzotriazine inhibitors of kinases
7208493	Vasculostatic agents and methods of use thereof

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 137 times since April 2007, the link to the organisation's website has been followed 33 times

Search for more companies in San Diego

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for TargeGen, Incorporated.